U.S. markets open in 4 hours 35 minutes

AMAG Pharmaceuticals, Inc. (AMAG)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.70+0.02 (+0.15%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/23/2020
Current
6/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
471.31M263.64M211.77M413.77M391.72M
Enterprise Value 3
632.08M443.44M340.92M502.69M407.38M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
30.40N/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
1.560.810.641.281.09
Price/Book (mrq)
1.891.000.740.860.78
Enterprise Value/Revenue 3
2.128.414.975.604.84
Enterprise Value/EBITDA 6
-3.23160.14-43.49-2.79-32.49

Trading Information

Stock Price History

Beta (5Y Monthly) 1.03
52-Week Change 332.37%
S&P500 52-Week Change 311.29%
52 Week High 313.80
52 Week Low 34.41
50-Day Moving Average 311.55
200-Day Moving Average 39.35

Share Statistics

Avg Vol (3 month) 31.45M
Avg Vol (10 day) 31.15M
Shares Outstanding 534.5M
Float 23.16M
% Held by Insiders 11.74%
% Held by Institutions 1134.32%
Shares Short (Oct 14, 2020) 47.23M
Short Ratio (Oct 14, 2020) 42.32
Short % of Float (Oct 14, 2020) 443.69%
Short % of Shares Outstanding (Oct 14, 2020) 420.95%
Shares Short (prior month Sep 14, 2020) 410.16M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 23:2
Last Split Date 3Sep 25, 1991

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin -86.95%
Operating Margin (ttm)-30.85%

Management Effectiveness

Return on Assets (ttm)-6.60%
Return on Equity (ttm)-69.13%

Income Statement

Revenue (ttm)297.7M
Revenue Per Share (ttm)8.74
Quarterly Revenue Growth (yoy)-32.20%
Gross Profit (ttm)177.7M
EBITDA -74M
Net Income Avi to Common (ttm)-258.84M
Diluted EPS (ttm)-7.60
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)147.12M
Total Cash Per Share (mrq)4.27
Total Debt (mrq)307.89M
Total Debt/Equity (mrq)123.49
Current Ratio (mrq)1.64
Book Value Per Share (mrq)7.23

Cash Flow Statement

Operating Cash Flow (ttm)-72.69M
Levered Free Cash Flow (ttm)-133.41M